SCHEMBL17322845

SCHEMBL17322845

COC(=O)Cn1nc(-c2cc(F)ccc2F)c2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.63
▸ ALDH1A1 P00352 2/20 0.63
▸ LMNA P02545 2/20 0.63
▸ KMT2A Q03164 2/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.63
▸ HPGD P15428 1/20 0.63
▸ HTT P42858 1/20 0.63
▸ MAPT P10636 3/20 0.54
▸ TSHR P16473 1/20 0.47
▸ HSD17B10 Q99714 3/20 0.44
▸ RORC P51449 1/20 0.43
▸ HK1 P19367 1/20 0.40
▸ HKDC1 Q2TB90 1/20 0.40
▸ GAA P10253 1/20 0.39
▸ TP53 P04637 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ S1PR1 P21453 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17322884 0.91 KDM4E (0.63) KDM4EALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL17322851 0.90 KDM4E (0.62) KDM4EALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL17322887 0.90 KMT2A (0.62) KDM4EALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL17322837 0.88 KDM4E (0.69) KDM4EALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL17326575 0.87 ALDH1A1 (0.58) KDM4EALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL17326653 0.84 KMT2A (0.55) KDM4EALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL17322838 0.84 ALDH1A1 (0.57) KDM4EALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL15631877 0.83 KDM4E (0.81) KDM4EALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL17322846 0.83 KDM4E (0.65) KDM4EALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL15631852 0.83 KDM4E (0.76) KDM4EALDH1A1LMNAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11426923-B2 Method for manufacturing a sleeved product FUJI SEAL INTERNATIONAL, INC. (JP) 2022-08-30 — — US disclosed
US-9738610-B2 Indazole derivatives and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2017-08-22 — — US disclosed
US-9738610-B2 Indazole derivatives and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2017-08-22 — — US disclosed
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2015-12-10 — — US disclosed
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2015-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF CYP11B1, HSP90B1, CYP1B1 KDM4E 4525/4885ALDH1A1 1340/4885LMNA 3513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback